No Evidence of Presence of Parvovirus 4 in a Swedish Cohort of Severely Immunocompromised Children and Adults

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Tolfvenstam, Thomas ^a   Norbeck, Oscar ^a   Öhrmalm, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER PATIENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOCOMPROMISED PATIENT; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PARVOVIRUS 4; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; SPECIES COMPARISON; SWEDEN; SWEDISH; VIRUS IDENTIFICATION;

ADOLESCENT; ADULT; CHILD; DNA, VIRAL; HUMANS; IMMUNOCOMPROMISED HOST; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PARVOVIRUS 4; PARVOVIRUS;

EID: 84866872427     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046430     Document Type: Article

References (32)

1. Jones MS, Kapoor A, Lukashov VV, Simmonds P, Hecht F, et al. (2005) New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79: 8230-8236.
2. Simmonds P, Douglas J, Bestetti G, Longhi E, Antinori S, et al. (2008) A third genotype of the human parvovirus PARV4 in sub-Saharan Africa. J Gen Virol 89: 2299-2302.
3. Fryer JF, Kapoor A, Minor PD, Delwart E, Baylis SA, (2006) Novel parvovirus and related variant in human plasma. Emerg Infect Dis 12: 151-154.
4. Lahtinen A, Kivela P, Hedman L, Kumar A, Kantele A, et al. (2011) Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis 17: 79-82.
5. Yu X, Zhang J, Hong L, Wang J, Yuan Z, et al. (2012) High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai. PLoS One 7: e29474.
6. Simmons R, Sharp C, McClure CP, Rohrbach J, Kovari H, et al. (2012) Parvovirus 4 Infection and Clinical Outcome in High-Risk Populations. J Infect Dis.
7. Yang SJ, Hung CC, Chang SY, Lee KL, Chen MY, (2011) Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection. J Clin Virol 51: 64-67.
8. Simmons R, Sharp C, Sims S, Kloverpris H, Goulder P, et al. (2011) High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis 203: 1378-1387.
9. Sharp CP, Lail A, Donfield S, Simmons R, Leen C, et al. (2009) High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. J Infect Dis 200: 1119-1125.
10. Manning A, Willey SJ, Bell JE, Simmonds P, (2007) Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J Infect Dis 195: 1345-1352.
11. Longhi E, Bestetti G, Acquaviva V, Foschi A, Piolini R, et al. (2007) Human parvovirus 4 in the bone marrow of Italian patients with AIDS. AIDS 21: 1481-1483.
12. Fryer JF, Lucas SB, Padley D, Baylis SA, (2007) Parvoviruses PARV4/5 in hepatitis C virus-infected patient. Emerg Infect Dis 13: 175-176.
13. Lurcharchaiwong W, Chieochansin T, Payungporn S, Theamboonlers A, Poovorawan Y, (2008) Parvovirus 4 (PARV4) in serum of intravenous drug users and blood donors. Infection 36: 488-491.
14. Simmonds P, Manning A, Kenneil R, Carnie FW, Bell JE, (2007) Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis 13: 1386-1388.
15. Ma YY, Guo Y, Zhao X, Wang Z, Lv MM, et al. (2012) Human parvovirus PARV4 in plasma pools of Chinese origin. Vox Sang.
16. Szelei J, Liu K, Li Y, Fernandes S, Tijssen P, (2010) Parvovirus 4-like virus in blood products. Emerg Infect Dis 16: 561-564.
17. Schneider B, Fryer JF, Oldenburg J, Brackmann HH, Baylis SA, et al. (2008) Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4. Haemophilia 14: 978-986.
18. Fryer JF, Hubbard AR, Baylis SA, (2007) Human parvovirus PARV4 in clotting factor VIII concentrates. Vox Sang 93: 341-347.
19. Fryer JF, Delwart E, Hecht FM, Bernardin F, Jones MS, et al. (2007) Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47: 1054-1061.
20. Sharp CP, Lail A, Donfield S, Gomperts ED, Simmonds P (2011) Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion.
21. Lavoie M, Sharp CP, Pepin J, Pennington C, Foupouapouognigni Y, et al. (2012) Human parvovirus 4 infection, cameroon. Emerg Infect Dis 18: 680-683.
22. Sharp CP, Vermeulen M, Nebie Y, Djoko CF, LeBreton M, et al. (2010) Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis 16: 1605-1607.
23. Panning M, Kobbe R, Vollbach S, Drexler JF, Adjei S, et al. (2010) Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis 16: 1143-1146.
24. Chen MY, Yang SJ, Hung CC, (2011) Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan. Emerg Infect Dis 17: 1954-1956.
25. Touinssi M, Brisbarre N, Picard C, Frassati C, Dussol B, et al. (2010) Parvovirus 4 in blood donors, France. Emerg Infect Dis 16: 165-166.
26. Servant-Delmas A, Laperche S, Mercier M, Elghouzzi MH, Lionnet F, et al. (2009) Human parvovirus 4 in recipients of cellular products and in blood donors: epidemiologic similarity with B19 parvovirus. Transfusion 49: 1771-1773.
27. Botto S, Bergallo M, Sidoti F, Terlizzi ME, Astegiano S, et al. (2009) Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens. New Microbiol 32: 189-192.
28. Vallerini D, Barozzi P, Quadrelli C, Bosco R, Potenza L, et al. (2008) Parvoviruses in blood donors and transplant patients, Italy. Emerg Infect Dis 14: 185-186.
29. Biagini P, Dussol B, Touinssi M, Brunet P, Picard C, et al. (2008) Human parvovirus 4 in kidney transplant patients, France. Emerg Infect Dis 14: 1811-1812.
30. Schneider B, Fryer JF, Reber U, Fischer HP, Tolba RH, et al. (2008) Persistence of novel human parvovirus PARV4 in liver tissue of adults. J Med Virol 80: 345-351.
31. Lindblom A, Isa A, Norbeck O, Wolf S, Johansson B, et al. (2005) Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 41: 1201-1203.
32. Touinssi M, Reynaud-Gaubert M, Gomez C, Thomas P, Dussol B, et al. (2011) Parvovirus 4 in French in-patients: a study of hemodialysis and lung transplant cohorts. J Med Virol 83: 717-720.